The Searle Company Limited (PSX:SEARL)

Pakistan · Delayed Price · Currency is PKR

94.40

-1.52 (-1.58%)

At close: Jun 19, 2026

25.85% (1Y)

Market Cap	55.53B +20.8%
Revenue (ttm)	35.99B +23.6%
Net Income	1.21B
EPS	2.06
Shares Out	588.22M
PE Ratio	25.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,206,111
Open	95.92
Previous Close	95.92
Day's Range	93.80 - 97.02
52-Week Range	66.96 - 137.44
Beta	0.48
Analysts	Buy
Price Target	104.35 (+10.54%)
Earnings Date	Oct 6, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1965

Employees 3,799

Stock Exchange Pakistan Stock Exchange

Ticker Symbol SEARL

Full Company Profile

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.

Financial Statements